Ocugen

Shankar Musunuri, Ph.D., Co-founder, Chairman and CEO

Oct. 12 | 2:00pm | UBC Ballroom  

Malvern, PA 

(NASDAQ: OCGN) 

In-person Presentation 

Ocugen is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologicals, and vaccines that improve health and offer hope for people and global communities. We are making an impact through courageous innovation, taking science in new directions in service of patients. Our breakthrough modifier gene therapy platform has the potential to treat multiple diseases with one drug and we are advancing research in other therapeutic areas to offer new options for people with unmet medical needs. 

www.ocugen.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions